NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced the third closing of its inaugural global life sciences fund, bringing total capital...
Hence then, the article about kos biotechnology partners announces third closing of global life sciences fund at 123 million was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million )
Also on site :
- William Shatner, 95, Walked Onstage With a Band Nobody Expected Him to Front; the ‘Star Trek’ Legend Covered Ozzy Osbourne and Metallica in Chicago
- Convera and JustLogin Partner to Enable Cross-Border Payroll and Payments Across Singapore and Southeast Asia
- Trump Gets Caught in a Dilemma Over a Saudi Plea for Military Help